The patient with chronic kidney disease (CKD) represents an extreme model for
arteriosclerosis, vascular calcification, and bone disorders, all of which are also associated …

Chronic kidney disease mineral and bone disorder (MBD) encompasses changes in mineral
ion and vitamin D metabolism that are widespread in the setting of chronic kidney disease …

Chronic kidney disease (CKD) is accompanied by disturbances in calcium, phosphate,
vitamin D, and parathyroid hormone (PTH) homeostasis that play an important role in the …

Recent reports of several bone-derived substances, some of which have hormonal
properties, have shed new light on the bone–cardiovascular axis. Deranged concentrations …

Chronic kidney disease (CKD) is a highly prevalent disease that has become a public health
problem. Progression of CKD is associated with serious complications, including the …

Chronic kidney disease-mineral and bone disorder (CKD-MBD) defines a triad of
interrelated abnormalities of serum biochemistry, bone and the vasculature associated with …

The increased awareness of the potential role played by mineral and bone disorder in the
appearance of cardiovascular disease in renal patients has produced research efforts aimed …

Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney
disease (CKD). Multiple factors account for the increased incidence of cardiovascular …

Chronic kidney disease (CKD) is now recognized as a major public health issue. One
consequence of this condition is disturbance of mineral and bone homeostasis. Bone …

Osteoporosis characterized by low bone mineral density (BMD) as assessed by dual-energy
X-ray absorptiometry (DXA) is common among end-stage renal disease (ESRD) patients …